Skip to main content
Top
Published in: BMC Nephrology 1/2012

Open Access 01-12-2012 | Research article

Association between serum insulin-like growth factor I or IGF-binding protein 3 and estimated glomerular filtration rate: results of a population-based sample

Authors: Kathleen Dittmann, Henri Wallaschofski, Rainer Rettig, Sylvia Stracke, Karlhans Endlich, Henry Völzke, Matthias Nauck, Nele Friedrich

Published in: BMC Nephrology | Issue 1/2012

Login to get access

Abstract

Background

Insulin-like growth factor I (IGF-I), which is mostly carried in blood by IGF-binding protein 3 (IGFBP-3), was associated to the glomerular filtration rate and chronic kidney disease in a multiethnic study among US adults. The aim of the present study was to investigate whether serum IGF-I or IGFBP-3 are associated with estimated glomerular filtration rate (eGFR) in a population-based study of Caucasian adults.

Methods

Data from 4028 subjects (2048 women) aged 20 to 81 years from the Study of Health in Pomerania (SHIP) were analyzed. Total serum IGF-I and IGFBP-3 concentrations were determined by chemiluminescence immunoassays and categorized into sex- and age-specific quartiles.

Results

After adjusting for age, waist circumference and type 2 diabetes mellitus, analysis of variance (ANOVA) revealed inverse associations between serum IGF-I concentrations and eGFR in men as well as between serum IGFBP-3 concentrations and eGFR in men and women. Logistic regression analyses confirmed these findings and showed that high IGF-I or IGFBP-3 concentrations were associated with an increased risk of decreased eGFR (<60 mL/min/1.73 m2) in men or women. These relations became stronger when lower eGFR cut-offs were used for the analyses.

Conclusion

Our data revealed associations of increased serum IGF-I concentrations and decreased eGFR in men but not in women and an association of increased serum IGFBP-3 concentrations and decreased eGFR in both sexes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Juul A: Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res. 2003, 13: 113-170. 10.1016/S1096-6374(03)00038-8.CrossRefPubMed Juul A: Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res. 2003, 13: 113-170. 10.1016/S1096-6374(03)00038-8.CrossRefPubMed
2.
go back to reference Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 1995, 16: 3-34.PubMed Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 1995, 16: 3-34.PubMed
3.
go back to reference Frystyk J, Ivarsen P, Skjaerbaek C, Flyvbjerg A, Pedersen EB, Orskov H: Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure. Kidney Int. 1999, 56: 2076-2084. 10.1046/j.1523-1755.1999.00798.x.CrossRefPubMed Frystyk J, Ivarsen P, Skjaerbaek C, Flyvbjerg A, Pedersen EB, Orskov H: Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure. Kidney Int. 1999, 56: 2076-2084. 10.1046/j.1523-1755.1999.00798.x.CrossRefPubMed
4.
go back to reference Perticone F, Maio R, Sciacqua A, Perticone M, Laino I, Miceli S, Mazzaferro D, Pascale A, Andreozzi F, Giorgio S: Insulin-like growth factor-1 and glomerular filtration rate in hypertensive patients. J Hypertens. 2009, 27: 613-617. 10.1097/HJH.0b013e32831fda24.CrossRefPubMed Perticone F, Maio R, Sciacqua A, Perticone M, Laino I, Miceli S, Mazzaferro D, Pascale A, Andreozzi F, Giorgio S: Insulin-like growth factor-1 and glomerular filtration rate in hypertensive patients. J Hypertens. 2009, 27: 613-617. 10.1097/HJH.0b013e32831fda24.CrossRefPubMed
5.
go back to reference Colao A, Di Somma C, Cascella T, Pivonello R, Vitale G, Grasso LF, Lombardi G, Savastano S: Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects. Eur J Endocrinol. 2008, 159: 389-397. 10.1530/EJE-08-0201.CrossRefPubMed Colao A, Di Somma C, Cascella T, Pivonello R, Vitale G, Grasso LF, Lombardi G, Savastano S: Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects. Eur J Endocrinol. 2008, 159: 389-397. 10.1530/EJE-08-0201.CrossRefPubMed
6.
go back to reference Kalantar-Zadeh K, Unruh M: Health related quality of life in patients with chronic kidney disease. Int Urol Nephrol. 2005, 37: 367-378. 10.1007/s11255-004-0012-4.CrossRefPubMed Kalantar-Zadeh K, Unruh M: Health related quality of life in patients with chronic kidney disease. Int Urol Nephrol. 2005, 37: 367-378. 10.1007/s11255-004-0012-4.CrossRefPubMed
7.
go back to reference Perovic S, Jankovic S: Renal transplantation vs hemodialysis: cost-effectiveness analysis. Vojnosanit Pregl. 2009, 66: 639-644. 10.2298/VSP0908639P.CrossRefPubMed Perovic S, Jankovic S: Renal transplantation vs hemodialysis: cost-effectiveness analysis. Vojnosanit Pregl. 2009, 66: 639-644. 10.2298/VSP0908639P.CrossRefPubMed
8.
go back to reference Lepenies J, Wu Z, Stewart PM, Strasburger CJ, Quinkler M: IGF-1, IGFBP-3 and ALS in adult patients with chronic kidney disease. Growth Horm IGF Res. 2010, 20: 93-100. 10.1016/j.ghir.2009.10.002.CrossRefPubMed Lepenies J, Wu Z, Stewart PM, Strasburger CJ, Quinkler M: IGF-1, IGFBP-3 and ALS in adult patients with chronic kidney disease. Growth Horm IGF Res. 2010, 20: 93-100. 10.1016/j.ghir.2009.10.002.CrossRefPubMed
9.
go back to reference Atamer A, Alisir Ecder S, Akkus Z, Kocyigit Y, Atamer Y, Ilhan N, Ecder T: Relationship between leptin, insulin resistance, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in patients with chronic kidney disease. J Int Med Res. 2008, 36: 522-528.CrossRefPubMed Atamer A, Alisir Ecder S, Akkus Z, Kocyigit Y, Atamer Y, Ilhan N, Ecder T: Relationship between leptin, insulin resistance, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in patients with chronic kidney disease. J Int Med Res. 2008, 36: 522-528.CrossRefPubMed
10.
go back to reference Teppala S, Shankar A, Sabanayagam C: Association between IGF-1 and chronic kidney disease among US adults. Clin Exp Nephrol. 2010, 14: 440-444. 10.1007/s10157-010-0307-y.CrossRefPubMed Teppala S, Shankar A, Sabanayagam C: Association between IGF-1 and chronic kidney disease among US adults. Clin Exp Nephrol. 2010, 14: 440-444. 10.1007/s10157-010-0307-y.CrossRefPubMed
11.
go back to reference Volzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, Aumann N, Lau K, Piontek M, Born G, et al: Cohort profile: the study of health in pomerania. Int J Epidemiol. 2011, 40: 294-307. 10.1093/ije/dyp394.CrossRefPubMed Volzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, Aumann N, Lau K, Piontek M, Born G, et al: Cohort profile: the study of health in pomerania. Int J Epidemiol. 2011, 40: 294-307. 10.1093/ije/dyp394.CrossRefPubMed
12.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999, 130: 461-470.CrossRefPubMed Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999, 130: 461-470.CrossRefPubMed
13.
go back to reference Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003, 139: 137-147.CrossRefPubMed Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003, 139: 137-147.CrossRefPubMed
14.
go back to reference Friedrich N, Alte D, Volzke H, Spilcke-Liss E, Ludemann J, Lerch MM, Kohlmann T, Nauck M, Wallaschofski H: Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP). Growth Horm IGF Res. 2008, 18: 228-237. 10.1016/j.ghir.2007.09.005.CrossRefPubMed Friedrich N, Alte D, Volzke H, Spilcke-Liss E, Ludemann J, Lerch MM, Kohlmann T, Nauck M, Wallaschofski H: Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP). Growth Horm IGF Res. 2008, 18: 228-237. 10.1016/j.ghir.2007.09.005.CrossRefPubMed
15.
go back to reference Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, Toivanen L, Koskenvuo M, Leinonen P, Koistinen R, Seppala M: Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest. 1996, 98: 2612-2615. 10.1172/JCI119081.CrossRefPubMedPubMedCentral Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, Toivanen L, Koskenvuo M, Leinonen P, Koistinen R, Seppala M: Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest. 1996, 98: 2612-2615. 10.1172/JCI119081.CrossRefPubMedPubMedCentral
16.
go back to reference Iglesias P, Diez JJ, Fernandez-Reyes MJ, Mendez J, Bajo MA, Aguilera A, Selgas R: Growth hormone, IGF-I and its binding proteins (IGFBP-1 and −3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis. Clin Endocrinol (Oxf). 2004, 60: 741-749. 10.1111/j.1365-2265.2004.02049.x.CrossRef Iglesias P, Diez JJ, Fernandez-Reyes MJ, Mendez J, Bajo MA, Aguilera A, Selgas R: Growth hormone, IGF-I and its binding proteins (IGFBP-1 and −3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis. Clin Endocrinol (Oxf). 2004, 60: 741-749. 10.1111/j.1365-2265.2004.02049.x.CrossRef
17.
go back to reference Jehle PM, Ostertag A, Schulten K, Schulz W, Jehle DR, Stracke S, Fiedler R, Deuber HJ, Keller F, Boehm BO, et al: Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy. Kidney Int. 2000, 57: 423-436. 10.1046/j.1523-1755.2000.00862.x.CrossRefPubMed Jehle PM, Ostertag A, Schulten K, Schulz W, Jehle DR, Stracke S, Fiedler R, Deuber HJ, Keller F, Boehm BO, et al: Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy. Kidney Int. 2000, 57: 423-436. 10.1046/j.1523-1755.2000.00862.x.CrossRefPubMed
18.
go back to reference Mahesh S, Kaskel F: Growth hormone axis in chronic kidney disease. Pediatr Nephrol. 2008, 23: 41-48.CrossRefPubMed Mahesh S, Kaskel F: Growth hormone axis in chronic kidney disease. Pediatr Nephrol. 2008, 23: 41-48.CrossRefPubMed
19.
go back to reference Ballmer PE, McNurlan MA, Hulter HN, Anderson SE, Garlick PJ, Krapf R: Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J Clin Invest. 1995, 95: 39-45. 10.1172/JCI117668.CrossRefPubMedPubMedCentral Ballmer PE, McNurlan MA, Hulter HN, Anderson SE, Garlick PJ, Krapf R: Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J Clin Invest. 1995, 95: 39-45. 10.1172/JCI117668.CrossRefPubMedPubMedCentral
20.
go back to reference Handelsman DJ: Hypothalamic-pituitary gonadal dysfunction in renal failure, dialysis and renal transplantation. Endocr Rev. 1985, 6: 151-182. 10.1210/edrv-6-2-151.CrossRefPubMed Handelsman DJ: Hypothalamic-pituitary gonadal dysfunction in renal failure, dialysis and renal transplantation. Endocr Rev. 1985, 6: 151-182. 10.1210/edrv-6-2-151.CrossRefPubMed
21.
go back to reference Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX: Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006, 17: 2034-2047. 10.1681/ASN.2005101085.CrossRefPubMed Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX: Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006, 17: 2034-2047. 10.1681/ASN.2005101085.CrossRefPubMed
22.
go back to reference Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010, 375: 2073-2081.CrossRefPubMedPubMedCentral Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010, 375: 2073-2081.CrossRefPubMedPubMedCentral
23.
go back to reference Friedrich N, Haring R, Nauck M, Ludemann J, Rosskopf D, Spilcke-Liss E, Felix SB, Dorr M, Brabant G, Volzke H, Wallaschofski H: Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations. J Clin Endocrinol Metab. 2009, 94: 1732-1739. 10.1210/jc.2008-2138.CrossRefPubMed Friedrich N, Haring R, Nauck M, Ludemann J, Rosskopf D, Spilcke-Liss E, Felix SB, Dorr M, Brabant G, Volzke H, Wallaschofski H: Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations. J Clin Endocrinol Metab. 2009, 94: 1732-1739. 10.1210/jc.2008-2138.CrossRefPubMed
24.
go back to reference Burgers AM, Biermasz NR, Schoones JW, Pereira AM, Renehan AG, Zwahlen M, Egger M, Dekkers OM: Meta-analysis and dose–response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. J Clin Endocrinol Metab. 2011, 96 (9): 2912-2920. 10.1210/jc.2011-1377.CrossRefPubMed Burgers AM, Biermasz NR, Schoones JW, Pereira AM, Renehan AG, Zwahlen M, Egger M, Dekkers OM: Meta-analysis and dose–response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. J Clin Endocrinol Metab. 2011, 96 (9): 2912-2920. 10.1210/jc.2011-1377.CrossRefPubMed
25.
go back to reference Blum WF, Breier BH: Radioimmunoassays for IGFs and IGFBPs. Growth Regul. 1994, 4 (Suppl 1): 11-19.PubMed Blum WF, Breier BH: Radioimmunoassays for IGFs and IGFBPs. Growth Regul. 1994, 4 (Suppl 1): 11-19.PubMed
Metadata
Title
Association between serum insulin-like growth factor I or IGF-binding protein 3 and estimated glomerular filtration rate: results of a population-based sample
Authors
Kathleen Dittmann
Henri Wallaschofski
Rainer Rettig
Sylvia Stracke
Karlhans Endlich
Henry Völzke
Matthias Nauck
Nele Friedrich
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2012
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-13-169

Other articles of this Issue 1/2012

BMC Nephrology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.